Efficacy and Acceptability of Two Lubricant Eye Drops

Study Identifier
MA-OPT-08-001
CT.gov Identifier
NCT00756678
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Lubricant Eye Drops (Optive™)
  • Lubricating Eye Drops (blink® Tears)
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Male or Female * At least 18 years of age * Current use of artificial tears
    Exclusion Criteria:
    * Any uncontrolled systemic disease * Pregnancy or planning a pregnancy * Contact lens wear

    Protocol Summary

    Efficacy and acceptability of two new artificial tears following two weeks of treatment in patients with dry eye. Patients will be randomized to 1 of 2 treatments for 7 days then crossover to the alternate treatment for 7 days.

    Study Locations

    Location
    Status
    Location
    Chevy Chase, Maryland, United States
    Status
    Not applicable